Morris Nichols Bankruptcy Alert - Novum Pharma, LLC Files Chapter 11 Bankruptcy Case in Delaware
On February 3, 2019, Novum Pharma, LLC filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. As a courtesy to our clients and friends, the Morris Nichols Business Reorganization & Restructuring Group has summarized information related to the filing below.
Lead Case No. – 19-10209.
Debtor – Novum Pharma, LLC.
Description of Debtor – Specialty pharmaceutical company.
Website of Debtor's (URL) – www.novumrx.com.
Assigned Judge – The Honorable Kevin J. Carey.
Proposed Counsel – The Debtor's proposed bankruptcy counsel is Cole Schotz P.C.
Proposed Financial Advisor – CR3 Partners, LLC.
Proposed Investment Banker – Teneo Capital LLC.
Proposed CRO – Thomas S. O'Donoghue, Jr.
Plan Status – No plan was filed with the petition.
First Day Hearing – A first day hearing has been scheduled for February 5, 2019 at 2:30 p.m. ET.
Bankruptcy Documents –
Please do not hesitate to contact any member of the Morris Nichols Business Reorganization & Restructuring Group if we can be of assistance.